We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$100M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$97M
3
LRCX icon
Lam Research
LRCX
+$85.4M
4
BSX icon
Boston Scientific
BSX
+$79.4M
5
MRK icon
Merck
MRK
+$67M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
301
Heron Therapeutics
HRTX
$94.5M
$3.26M 0.05%
569,155
+11,356
+2% +$83.1K
FSNB
302
DELISTED
Fusion Acquisition Corp. II
FSNB
$3.18M 0.05%
324,992
– –
LGV
303
DELISTED
Longview Acquisition Corp. II
LGV
$3.17M 0.05%
325,000
– –
PRAX icon
304
Praxis Precision Medicines
PRAX
$10.3B
$3.15M 0.05%
20,583
– –
CLYM
305
Climb Bio
CLYM
$802M
$3.13M 0.05%
373,368
– –
PARA
306
DELISTED
Paramount Global Class B
PARA
$3.12M 0.05%
82,529
-285,241
-78% -$9.72M
IOVA icon
307
Iovance Biotherapeutics
IOVA
$2.77B
$3.11M 0.05%
186,864
-431,839
-70% -$6.68M
ROKU icon
308
Roku
ROKU
$22.3B
$3.08M 0.05%
+24,592
New +$3.61M
NRIX icon
309
Nurix Therapeutics
NRIX
$2.62B
$3.07M 0.05%
219,281
-373,660
-63% -$6.63M
DHBC
310
DELISTED
DHB Capital Corp. Class A common stock
DHBC
$3.02M 0.05%
309,939
– –
HCMAU
311
DELISTED
HCM Acquisition Corp Unit
HCMAU
$3M 0.05%
+300,000
New +$3M
OPA
312
DELISTED
Magnum Opus Acquisition Limited
OPA
$2.97M 0.05%
300,003
– –
CPTK
313
DELISTED
Crown PropTech Acquisitions
CPTK
$2.96M 0.05%
300,001
– –
NFNT
314
DELISTED
Infinite Acquisition Corp.
NFNT
$2.96M 0.05%
+299,999
New +$2.95M
GROV icon
315
Grove Collaborative
GROV
$47.1M
$2.96M 0.05%
60,000
– –
PRVA icon
316
Privia Health
PRVA
$2.77B
$2.96M 0.05%
110,553
-32,297
-23% -$763K
TBCP
317
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$2.95M 0.05%
300,000
– –
OMEG
318
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.95M 0.05%
300,000
– –
HHLA
319
DELISTED
HH&L Acquisition Co.
HHLA
$2.94M 0.05%
300,000
– –
RVAC
320
DELISTED
Riverview Acquisition Corp. Class A Common Stock
RVAC
$2.93M 0.05%
300,000
– –
KNTE
321
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$2.93M 0.05%
260,276
– –
FRXB
322
DELISTED
Forest Road Acquisition Corp. II
FRXB
$2.93M 0.05%
300,000
– –
CCAI
323
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
$2.92M 0.05%
300,000
– –
PEGR
324
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$2.92M 0.05%
+300,000
New +$2.91M
VLAT
325
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$2.92M 0.05%
300,000
– –
11 12
13
14 15

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.